An Evaluation of the Safety and Efficacy of LIPO-102 for the Reduction of Subcutaneous Abdominal Adiposity

A Double-Masked, Evaluation of the Safety and Efficacy of LIPO-102 for the Reduction of Subcutaneous Abdominal Adiposity

This is a double-masked evaluation of the safety and efficacy of LIPO-102 for the reduction of subcutaneous abdominal adiposity.

Inclusion Criteria:

• Male or non pregnant female
• Good general health
• Sufficient abdominal fat for injections
• Signed informed consent
• BMI greater than or equal to 18 and less than 28 kg/m2
• History of stable weight in past 3 months

Exclusion Criteria:

• Known hypersensitivity to study drugs
• Treatment with an investigational agent within 30 days of first dose